SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-18-063281
Filing Date
2018-12-06
Accepted
2018-12-06 09:52:09
Documents
3
Effectiveness Date
2018-12-06

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv508593_8k.htm DEFA14A 22975
2 EXHIBIT 99.1 tv508593_ex99-1.htm EX-99.1 14764
3 GRAPHIC image_001.jpg GRAPHIC 2917
  Complete submission text file 0001144204-18-063281.txt   42977
Mailing Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024 201-464-2677
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36602 | Film No.: 181219290
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1